IMMUNOVANT INC IMVT
COM · Common Stock · CUSIP 45258J102
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersDurham, NC
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($220.0k this quarter). Holder counts are more reliable. Shares outstanding: 56.5m as of 2020-02-14, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $15.14.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Roivant Sciences Ltd.
13D · may seek influence
-1.0 pts · filed 2025-12-12
Stated purposeItem 4 is hereby amended by adding the following to the end thereof: Roivant purchased an aggregate of 16,666,666 shares of Common Stock in the Offering to provide further capital to the Issuer for the advancement of the Issuer's development pipeline, working capital and other general corporate purposes, as well as to increase its ownership interest in the Issuer following the Offering. As the Issuer's largest shareholder, Roivant may provide additional financing to the Issuer from time to time in the form of an investment in equity or debt securities of the Issuer or loans, including in connection with business development transactions or financing commitments in relation thereto. Full filing |
55.9% |
| FMR LLC 13G · institution -1.7 pts · filed 2025-11-05 | 8.4% |
Fell to 5% or below in the last year: Deep Track Capital, LP (4.5%, 2026-08-14)
Insider purchases and sales in Q4 2019
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q4 2019.
Holders, Q4 2019
| Manager | Shares | Change |
|---|---|---|
| RTW INVESTMENTS, LP 2.49% of their portfolio | 4.4m $66.0m | — |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.04% of their portfolio | 1.0m $16.2m | — |
| BVF INC/IL 1.20% of their portfolio | 1,000.0k $15.8m | — |
| Ghost Tree Capital, LLC 3.43% of their portfolio | 800.0k $12.7m | — |
| Driehaus Capital Management LLC 0.26% of their portfolio | 621.5k $9.9m | — |
| Sio Capital Management, LLC 1.66% of their portfolio | 615.4k $5.5m | — |
| BlackRock Inc. 0.00% of their portfolio | 599.9k $9.5m | — |
| Ikarian Capital, LLC 7.36% of their portfolio | 504.1k $8.0m | — |
| Athanor Capital, LP 0.47% of their portfolio | 500.0k $7.9m | — |
| Polar Capital LLP 0.05% of their portfolio | 393.8k $6.2m | — |
| Woodline Partners LP 0.18% of their portfolio | 272.5k $4.3m | — |
| Prosight Management, LP 1.63% of their portfolio | 224.7k $3.6m | — |
| Granite Point Capital Management, L.P. 2.66% of their portfolio | 220.0k $3.5m | — |
| MANGROVE PARTNERS IM, LLC 0.24% of their portfolio | 100.0k $1.6m | — |
| Schonfeld Strategic Advisors LLC 0.03% of their portfolio | 85.0k $1.3m | — |
| BOOTHBAY FUND MANAGEMENT, LLC 0.14% of their portfolio | 84.7k $1.3m | — |
| Eversept Partners, LP 0.25% of their portfolio | 76.9k $1.2m | — |
| NORTHERN TRUST CORP 0.00% of their portfolio | 23.6k $374.0k | — |
| ExodusPoint Capital Management, LP 0.01% of their portfolio | 21.8k $346.0k | — |
| SPHERA FUNDS MANAGEMENT LTD. 0.04% of their portfolio | 20.0k $317.0k | — |
| PA Capital LLC 0.20% of their portfolio | 13.9k $220.0k | — |
| 683 Capital Management, LLC 0.03% of their portfolio | 13.4k $213.0k | — |
| UBS Group AG 0.00% of their portfolio | 1.1k $17.0k | — |
| MORGAN STANLEY 0.00% of their portfolio | 1.0k $16.0k | — |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | — |